View this email as a Web page Please add HC_HomeCare Monday_ to your Safe Sender list.
A Penton Media Property
May 3, 2010 Volume 16, Number 16

ADVERTISEMENT



ADVERTISEMENT
The new UltraFill home oxygen system combines a stationary oxygen concentrator, filling station, and high-capacity cylinders to meet the needs of a wide range of patients, including those who require continuous flow oxygen. UltraFill also has the needs of your business in mind with features intended to save you money.

http://UltraFill.Respironics.com


Table of Contents
- Attendees Look to Vendors for Answers at Medtrade Spring
- Invacare’s Mixon on Temporary Medical Leave
- American HomePatient to Restructure, Go Private
- CBIC Requests More Round 1 Bid Info in Short Order
- Cornerstone Medical Gets a Fragile New 'Customer'
- Bill Addresses Medicare Inequity for Mastectomy Patients
- Q&A: What the Patient Protection and Affordable Care Act Means to HME Suppliers
- From HomeCareMag.com: News You Can Use

For more industry news, features and highlights from our latest issue, please visit our Web site at www.homecaremag.com.

- Headline News
Attendees Look to Vendors for Answers at Medtrade Spring
ATLANTA—They are the survivors. They are going to Medtrade Spring in search of new ideas and opportunities. They are looking to be proactive in the midst of industry turmoil. They want to re-connect with colleagues. They seek to understand—and, yes, to commiserate about—how their beloved industry is changing. When this group of battle-weary but stalwart attendees converge on Las Vegas for Medtrade Spring, May 11-13 at the Sands Expo and Convention Center, exhibitors promise they will be well rewarded for making the trip.

“In today's changing industry, providers are having to find new and innovative ways to separate themselves from their competition while staying compliant with legislative changes,” said Bryan Sowards, CEO of Infopia USA. “Our goal at Medtrade Spring is to show how innovation in technology can help them achieve their goals while being mindful of compressed reimbursements.”
“Attendees will be looking for new ideas and, most importantly, answers,” said Sowards. “Pricing will be an important factor, but providers are really looking for vendors that can help them navigate through the changing landscape and provide solutions for problems they face within their industry, not just products.”

“When the industry is changing, it's not the time to sit back and allow yourself to be left behind,” he added. “Medtrade Spring allows for networking, learning and discovering solutions that can change the way providers do business for the better.”

Christina Brown, Infopia's marketing and events director, said the company’s booth at the show will be transformed into the “Carnival of Innovation," presented by the HME Providers group membership program and featuring Infopia’s diabetes products. The booth also will feature games, activities, carnival performers (including a magician) and “the world's largest mind-reading rabbit.” Infopia USA is again the Diamond Sponsor of the Homecare Works! networking reception, set for Wednesday, May 12, at 3:30 p.m. on the show floor.

“Medtrade affords us the opportunity to spend quality time with our customers and demonstrate our commitment to the home health care community,” said Maryellen Bizzack, director of marketing and communications, Philips Home Healthcare Solutions. The manufacturer’s “People focused. Healthcare simplified” slogan will be reflected in the booth theme at this year’s Expo: “If it’s a breakthrough in respiratory care, it is likely our innovation.”

Philips Respironics will display new products in the areas of sleep management, oxygen therapy, noninvasive ventilation and respiratory drug delivery, including recent releases such as the BiPAP autoSV Advanced sleep system, the new EasyLife mask, the BiPAP AVAPS ventilator and the UltraFill home oxygen filling system.

At Homecare by Moen, "Optimism is the key word," said Brad Crozier, senior product/brand manager. "We have started to see the economy turn around, and people in general are starting to feel better about their current situation and the future. Customers will be looking for what’s new, and [exhibitors] will be ready to show their new, innovative products coming to market." Moen will be introducing a new tub and shower seat, tool-free shower chair and suction balance-assist bar, Crozier said.

Another Medtrade Spring exhibitor, HME business software developer Brightree, has presented at a series of state association meetings where Vice President of Marketing Mark Blount said he has seen “a lot of solidarity” in the industry, especially as it relates to a possible repeal of competitive bidding. “It sounds to me like the momentum is building,” he said.

At Medtrade Spring, Brightree will unveil its latest release (No. 24), which integrates new functionality such as the ability to verify Medicare “same or similar” status for any patient and insurance eligibility for Medicaid and most commercial payers. The company has also announced plans to expand its core Brightree product to include fully integrated features for home infusion providers.

Home infusion is an $11 billion market projected to grow to $16 billion by 2012, according to the company. “As HME/DME providers search for ways to recover from reimbursement cuts and oxygen caps, many owners see a great opportunity to diversify their business by expanding into the home infusion market,” said Dave Cormack, Brightree’s CEO. “Having a single, integrated software platform to manage a provider’s DME and infusion operations will make that transition as easy as possible.”


Blount recommends attending Medtrade Spring with “an open mind and an empty notebook.

“I believe it's dangerous to put your head in the sand no matter how bad you think things are,” said Blount. “Take in as much as you can, network with others, learn from the sessions and Expo floor,” he said. “On top of all that, the extra benefit you get is you come back home energized because you have realized all the good things going on in the market. It's not all bad.”

Attendees at Medtrade Spring will be there because they desire not just to survive but to flourish, said Miriam Lieber of Lieber Consulting, Sherman Oaks, Calif. “They understand the need to diversify and get new ideas from their peers, from vendors and from the educational programs.”

The show will provide an infusion of new ideas and opportunities, she said, and attendees will be viewing the products in the context of dealing with the challenges of reimbursement cuts and competitive bidding.

“People will be visiting the show floor for more information on competitive bidding and how they will need to purchase differently, looking at which vendors' products will provide the return they need to deliver on a three-year contract,” said Lieber, adding that pricing will be a big consideration.

“The buzz on the show floor will be about the new and changing environment,” Lieber predicted.
Ironically, the hard economic times should translate into an even more attentive group at the spring show, she reasoned. “When you spend the money [to travel to the show] in this economy, you are very conscious of it, and you look to get more from it than in the past. It's an expense, but providers expect to get a return on the investment.”


At Medtrade Spring, choose from more than 70 sessions in 12 tracks, including reimbursement, business operations and information technology. The conference will also offer several “Hot Topics” sessions on competitive bidding, HME retail and effective grassroots lobbying. In addition, the American Association for Homecare will present its informative “Washington Update” on Wednesday, May 12.

For more information, see www.medtradespring.com. Check with any exhibitor for free passes to the Expo hall, and use Code HOME2000 for $50 off the Medtrade Spring conference fee, good until May 10.


HomeCare is the official publication of Medtrade. While you’re at the show, stop by Booth 1233 for your FREE subscription. We’ll see you there!


Invacare’s Mixon on Temporary Medical Leave
ELYRIA, Ohio—Invacare Corp. announced this morning that A. Malachi Mixon, III, chairman and CEO, is taking a temporary medical leave.

In the meantime, Gerald B. Blouch, president and COO, will be interim CEO. Blouch has been with the Company since May 1990 and has been Chief Operating Officer since December 1994. James C. Boland, Invacare’s lead director and a member of its board since 1998, will be interim chairman of the board of directors.

“I have suffered a mild stroke, but fortunately, my condition is stable and my doctors have told me the prognosis for a full recovery is favorable,” Mixon said in a press statement. “I look forward to returning to Invacare soon to full duty. In the interim, I am pleased to have Gerry Blouch and Jim Boland assume responsibility for my day-to-day activities as CEO and Chairman of Invacare.”

On behalf of the board, Boland commented, “In the interests of allowing Mal to focus on a speedy recovery, we are implementing a succession plan that we have had in place for some time. Gerry has the entire board’s complete support and has full authority to act as CEO during this time. We have every confidence that Invacare’s outstanding tenured management team will continue operations seamlessly.”

Invacare is the country’s largest manufacturer of home medical equipment. The company has 5,900 associates and markets its products in approximately 80 countries around the world.


American HomePatient to Restructure, Go Private
BRENTWOOD, Tenn.—In a move to avoid bankruptcy, American HomePatient announced last week that it would go private following a restructuring of its debt.

Under an agreement with its lenders, AHP, which operates in 33 states, would reincorporate in Nevada. Then Highland Capital Management, which tried to buy the company in 2006, will offer to buy AHP’s outstanding stock for 67 cents a share, according to a press release. Dallas-based Highland Capital currently owns 48 percent of the giant provider’s stock.

“We are pleased to have an agreement that provides fair value to our stockholders, extends our relationship with our debt holders, and allows American HomePatient and its employees to continue to focus on providing critical services to our customers,” Joseph F. Furlong, AHP president and CEO, said in the April 28 release.

After filing for bankruptcy in 2002, the company emerged from an 11-month reorganization in July 2003 with a plan giving it until 2009 to repay its debt.

But AHP defaulted on a $226 million promissory note when it missed its Aug. 1, 2009, repayment date. Since then, the company has been operating under a series of short-term forbearance agreements with NexBank SSB, a Highland Capital affiliate, in which its lenders agreed not to take any action against the company while negotiating a resolution. The parties had been working under the 10th such agreement, which was due to expire May 16.

According to the release:

If the reincorporation in Nevada is not approved, the tender offer and subsequent debt restructuring will not occur. If the tender offer is completed, the Company’s senior secured debt will be restructured with a new four-year term. If the tender offer is not completed, the company will remain in default of its obligations to its senior lenders, the consensual long-term restructuring of the company’s debt will not occur, and American HomePatient may make a Chapter 11 bankruptcy filing. The outcome for existing stockholders in any bankruptcy would be highly uncertain.

AHP said stockholders would vote on the plan at its annual meeting June 21.


CBIC Requests More Round 1 Bid Info in Short Order
BALTIMORE—The Competitive Bidding Implementation Contractor appeared to step up requests last week for more information from home medical equipment providers who submitted bids for Round 1 of the DMEPOS competitive bidding project.

Waterloo, Iowa-based VGM Group and the Texas Alliance for Home Care Services, as well as individual providers, reported that the CBIC, via email and hard-copy letters to bidders, was asking for more data on issues ranging from mail-order diabetic supplies, oxygen transfilling and hospital beds to state licenses.

“They are continuing to seek out information,” said Alan Morris, regulatory analyst for VGM. “They are going category by category. We may see more to come in the next few weeks, and then they should be done with the process and ready to move forward to calculate the composite and pivotal bids.”

CMS is expected to announce pricing for Round 1 in June, followed by bid winners in September.

Barry Johnson, CRT, president of Texas Medical in Duncanville, Texas, and president of TAHCS, said he had fielded numerous phone calls from the association’s members asking about the CBIC requests. On Tuesday, he, too, received an email from the CBIC asking for proof of licensure to provide hospital beds in Dallas.

There were two problems with the request, Johnson said: Texas does not require licensure to sell hospital beds, but it does call for a germicidal bedding license—which Johnson provided when he submitted his bid last year.

“The bid process has been closed for months and here they are coming back and asking for more information,” he said. “They set the deadline for the bids to be in, and they even had a covered document review date to let you know if there was anything missing. They told us our bids were complete, and now they have decided out of the blue to ask for additional information.”

The requests to his company and others sent Johnson to the phone to talk to a CBIC representative. He talked with two, but said neither could answer his questions satisfactorily or assure him that the license he did submit would satisfy the CBIC request.

The requested information was due by the stroke of midnight ET on Thursday, April 29, or it could signal the death knell to participation in the Round 1 bid, Johnson said. “Two days is not sufficient for anyone who has a question,” he said about the deadline to submit the documentation.

He added that four of six hospital bed providers who are members of TAHCS had been asked by the CBIC for further data. “Why didn’t everyone get one of these [requests]?” he asked the CBIC representative. Her answer: They should have. She could not explain why they didn’t, Johnson said.

Meanwhile, the CBIC also requested extra information from providers bidding on any product category except oxygen in Pittsburgh, Pa., who are not located in that competitive bidding area and do not have representatives that cover that area. Such providers, the CBIC said, must “submit a statement signed by your company’s authorized official certifying that you do not have any sales representatives that go into Pennsylvania to promote, sell or provide samples of equipment.”

Bidders on oxygen in Pittsburgh who are not located in that CBA and who also do not have sales representatives promoting or selling there were also asked to submit a statement that “you do not transfill oxygen and do not have any sales representatives that go into Pennsylvania to promote, sell or provide samples of equipment.”

VGM’s Morris said from "everything I have seen to date—and some providers may argue this is over the top—but it is within their authority,” he said of the CBIC's requests, adding that providers just needed “to respond to their requests fast and assume that as long as they do and they have the proper documentation to back it up, there is really no issue.”


In an article April 26, HomeCare Monday incorrectly attributed some information to the CBIC rather than to the VGM Group. For a correct version of "CMS Begins Round 1 Bid Verification," see www.homecaremag.com.


Cornerstone Medical Gets a Fragile New 'Customer'
ATLANTA—HME providers supply life-sustaining equipment to many diverse patients, but a call last week to Cornerstone Medical was unusual by any standard. Atlanta's “Home Oxygen Specialists” answered an urgent call Wednesday requesting oxygen equipment for a four-week-old baby orangutan at Zoo Atlanta.

“The customer service rep took the call and put them on hold to ask me, 'What do you think of this?'” said Andy Simmons Jr., Cornerstone’s vice president of field operations. “It's not your typical call.” Turns out the referral came from one of the zoo employees whose mother is a Cornerstone Medical patient.

When Miri, an 18-year-old Bornean orangutan, gave birth at the city’s zoo on March 30, the baby was small and not as active and alert as expected. When there had been no improvement after two days, animal management and veterinary teams decided to remove the baby from his mother to hand-rear the infant, which involves constant monitoring and round-the-clock care. About half the normal size for an infant orangutan, the fragile animal is being protected from possible infections and fed through a tube to make sure he gets the nutrition he needs.

A pediatric pulmonologist and cardiologist from nearby Children's Healthcare of Atlanta are consulting in treating the baby orangutan.

“We pulled the equipment together at the branch location and arrived at the zoo at 7 p.m.,” said Simmons. “The baby orangutan was quarantined, so we had to scrub up and wear protective coverings.” Accompanying Simmons on the unusual delivery were Michael Perkins, operations manager for Cornerstone Medical, and Jeff Hunter, a manager at the provider’s Atlanta location.

The room was warm, and there was a reclining chair where a zoo employee or nurse holds the baby orangutan 24 hours a day. A pulse oximeter was attached to its tiny foot, which was “about the size of your pinky,” said Simmons.

The baby orangutan had previously been breathing with the help of an oxygen tank. Cornerstone Medical replaced the tank with an oxygen concentrator and other equipment, including a pediatric flow adjustment to enable the oxygen flow to be reduced in line with the small-sized patient, and set at appropriate levels to encourage his lungs to develop.

“It was uncanny how much this orangutan looked like a real baby, especially the way [zoo employees] were caring for it,” said Simmons. “It was fussy a little bit. You could tell by the pulse oximeter that the heart rate escalated a little in the excitement of connecting the equipment. But overall it was very calm, very subdued. They picked it up and let me look at his face. It's a cute little fella.”

“We spent about three hours there training [the zoo team] on how to switch over the various modalities of the oxygen,” said Simmons. “We stayed to make sure the equipment was meeting the purpose and all the staff was comfortable with the equipment.” Simmons isn't sure how long the tiny animal will need the oxygen therapy, but Cornerstone Medical has committed to donate its services and use of the equipment as long as necessary.

Krissy Toth, local sales rep for Buffalo, N.Y.-based AirSep Corp., said the manufacturer would donate a 10-liter NewLife Intensity oxygen concentrator to Zoo Atlanta. Once delivered, it will be used to supply the baby orangutan's immediate oxygen needs and then kept by the zoo for any similar needs in the future.

Bornean orangutans are endangered because of over-harvesting of timber and human encroachment in their native habitat, according to officials at Zoo Atlanta. Experts predict the species could be extinct in 10 years without targeted conservation efforts.

Zoo Atlanta staff said once the new baby grows strong enough, he would be re-introduced to his orangutan family.

“We were glad to be a part of it,” said Simmons.


Do you plan to continue in the HME business? To vote in HomeCare's monthly Web poll, visit www.HomeCareMag.com.


Bill Addresses Medicare Inequity for Mastectomy Patients
WASHINGTON—With the aim of eliminating an inequity in Medicare coverage and providing another option to women who have undergone mastectomies for breast cancer, Sen. Blanche Lincoln, D-Ark., has introduced legislation calling for government coverage of custom-fabricated breast prostheses.

S. 3255, the Custom Fabricated Breast Prosthetics Act of 2010, would expressly provide coverage under Medicare for custom-fabricated breast prostheses. The latter allows a lower-cost alternative to reconstructive surgery; however, Medicare currently covers only non-custom fabricated silicone or foam forms.

“As the most common cancer among women, breast cancer touches the lives of millions,” Lincoln said. “The disease can be devastating both physically and psychologically, and for those who undergo a mastectomy, the impact is even greater … It is so important for breast cancer survivors to have access to affordable and viable options to ensure their best recovery possible.”

Lincoln noted that breasts remain the only body part whose custom-fabricated prosthetic replacement is not reimbursed by Medicare. That inequity deprives patients of a “valid, non-surgical alternative following a mastectomy” and pushes more women to the additionally risky, more expensive reconstructive surgery, experts say.

That gap in Medicare coverage is in spite of what many have called the “clear intent” of the Women’s Health and Cancer Rights Act of 1998, which mandated that private insurers and group health plans provide coverage for all stages of breast surgery and reconstruction for women undergoing medically necessary mastectomies.

“Under this new legislation, women and men will have a non-surgical option for breast restoration,” said Susan Cassidy, CEO of ContourMed, a Little Rock, Ark.-based manufacturer of custom-fabricated breast prostheses. She added that if the bill passes, it would provide “a medically necessary treatment option for thousands of women in Arkansas and millions of women across the nation.”

Rhonda Turner, president of the American Association of Breast Care Professionals, applauded Lincoln’s bill, which is cosponsored by Sen. Olympia Snowe, R-Maine.

“The Custom Fabricated Breast Prosthetic Act of 2010 addresses a baffling and illogical inequity in the provision of breast care and post-mastectomy coverage,” she said. “Simply put, a mastectomy is an amputation. And the replacement of body parts—both external and internal—requires custom treatment. However, when replacing an amputated breast, Medicare has been denying women this medically necessary treatment—custom breast forms.”

Twenty-six-year cancer survivor Becky Caruthers of Arkansas also supports the bill. A bilateral breast cancer patient, she said a custom breast “is a must” for her because two surgeries resulted in a difference of anatomy. She tried an off-the shelf model, which proved to be too heavy, too hot and did not contour with her chest wall, she said.

After four years, she was introduced to a custom breast form from ContourMed. “That changed my life,” she said. “It made me feel whole again.” The new form, she said, “took away the emotional struggle I was having and replaced it with the ability for me to swim and play with my child and have a life once again.”

Caruthers is such a champion of the custom fabricated prostheses that not long after wearing the new breast form, she went to work for ContourMed.

For the text of S. 3255, see thomas.loc.gov.


Q&A: What the Patient Protection and Affordable Care Act Means to HME Suppliers
AMARILLO, Texas—The Senate health reform bill, H.R. 3590, entitled the “Patient Protection and Affordable Care Act” (PPACA), was passed by the U.S. Senate on Dec. 24, 2009. The House of Representatives passed the Senate bill on March 22, 2010, and President Obama signed it into law on March 23. The PPACA, as written, will make things harder on HME suppliers by expanding the competitive bidding program, imposing a fee on device manufacturers and tightening reimbursement provisions, according to health care attorney Jeff Baird. Here’s Baird’s rundown on the new law.

Question: Does the PPACA affect Medicare reimbursement for power wheelchairs?
Answer: Yes. Sec. 3136 of the PPACA is entitled “Revision of payment for power driven wheelchairs.” This section provides that the purchase option will be available only to complex rehabilitation power wheelchairs. The purchase option will no longer be available to other power wheelchairs. Also, the rental payment amounts will change from 10 percent of the purchase price for the first three months and 7.5 percent for the remaining rental months, to 15 percent for the first three months and 6 percent for the remaining rental months.

Question: I understand that the health reform act affects CPI-U increases. Is this correct?
Answer: Yes. Sec. 3401 of the PPACA (“Productivity Improvements”) provides that, beginning with 2011, the CPI-U update will be reduced by a “productivity adjustment,” which may result in no CPI-U update for the year or payment rates for a year that are lower than the payment rates for the preceding year.

The definition of “productivity adjustment” is a mouthful. It is defined as “the 10-year moving average of changes in annual economy-wide private nonfarm business multi-factor productivity (as projected by the Secretary for the 10-year period ending with the applicable fiscal year, year, cost reporting period, or other annual period).” Note that the Bureau of Labor Statistics currently maintains data on private nonfarm business multifactor productivity.

Question: I have heard that the health reform act talks about provider/supplier screening and other enrollment requirements for Medicare, Medicaid and CHIP. Is this correct?
Answer: Yes. Sec. 6401 contains a number of requirements that affect HME suppliers. Specifically:

Provider/Supplier Screening. Providers and suppliers enrolling or re-enrolling in Medicare, Medicaid or CHIP will be subject to screening measures. The Department of Health and Human Services is required, within six months and in consultation with the Office of Inspector General, to establish procedures for screening providers and suppliers.

HHS is required to determine the level of screening according to the risk of fraud, waste and abuse with respect to each category of provider or supplier. All providers and suppliers will be subject to licensure checks and, if HHS so determines, additional screening measures such as criminal background checks, fingerprinting, database checks and unscheduled and unannounced site visits. In short, it will be more difficult for a new player to come into the industry and to successfully re-enroll. The owner of the HME company needs to be squeaky clean.

Disclosure Requirements. Providers and suppliers enrolling or re-enrolling in Medicare, Medicaid or CHIP will be subject to new disclosure requirements. Applicants will be required to disclose current or previous affiliations, directly or indirectly, with any provider or supplier that has uncollected debt, been subject to payment suspension under a federal health care program, been excluded from participating in a federal health care program or had its billing privileges denied or revoked. HHS may deny enrollment or re-enrollment if such affiliations pose an undue risk of fraud, waste or abuse. Not only must the owner of the HME company be squeaky clean, but the owner must be careful about who he/she has affiliated with, or done business with, in the past.

Offset payments from suppliers with same tax ID number. HHS may adjust payments to a provider or supplier that has the same tax ID number as a provider or supplier that owes past-due obligations under Medicare, Medicaid or CHIP, regardless of such providers’ or suppliers’ Medicare billing number or NPI.

Temporary Moratorium. HHS may impose a temporary moratorium on the enrollment of new providers and suppliers if HHS determines that such action is necessary to prevent or combat fraud, waste or abuse. Those people who have had to deal with the MediCal moratorium know that this is a train wreck waiting to happen.

Compliance Programs. Sometime in the future, certain providers and suppliers will be required to establish a compliance program that must contain core elements, which will be established by HHS in consultation with the OIG. Note that the OIG currently has compliance guidelines for various types of health care providers and suppliers, including DMEPOS suppliers. For a number of reasons, each HME supplier should have a compliance program now.

Question: Does the new legislation contain anti-fraud measures?
Answer: Yes. Sec. 6402 discusses overpayments, kickbacks, false claims and surety bonds. Specifically:

Reporting and Returning Overpayments. Any provider or supplier that receives an overpayment must report the overpayment to HHS, carrier or other appropriate person and provide written notice of the reason for the overpayment. An overpayment must be reported and returned no later than 60 days after it is identified or the date of any corresponding cost report (if applicable). Failure to do so may result in civil money penalties. Think of the ramifications. It is common to pay back money to the DME MAC. These reporting requirements will be onerous.

Anti-kickback Statute and False Claims Act. A claim that includes items or services resulting from a violation of the Medicare/Medicaid anti-kickback statute constitutes a false or fraudulent claim under the Civil False Claims Act (31 USC § 3729). This is nothing new. This has been the Department of Justice’s position for many years.

Surety Bonds. HHS must take into account the volume of billing for an HME supplier or home health agency when determining the size of the surety bond. In other words, the surety bonds will not be limited to $50,000.

Question: What about physicians?
Answer: Under Sec. 6405, physicians who order items or services will be required to be Medicare enrolled physicians or eligible professionals. On or after July 1, 2010, DME or home health services must be ordered by a Medicare-enrolled physician or eligible professional. HHS may extend these requirements to other Medicare items and services to reduce fraud, waste and abuse. (Note that, as of this writing, the deadline for physicians and non-physician practitioners who order DMEPOS items or services, or refer Medicare beneficiaries to Medicare-enrolled DMEPOS suppliers, to enroll in the Medicare Provider Enrollment, Chain and Ownership System, or PECOS, is Jan. 3, 2011. It is uncertain what effect, if any, the July 1, 2010, deadline will have on the PECOS deadline. We await guidance from CMS on this issue.)

Question: In the past, the worst thing that would happen to a supplier that did not have all of the required documentation was the assessment of an overpayment. Has this changed?
Answer: Unfortunately, yes. Under Sec. 6406, DHHS may revoke enrollment of a physician or supplier for failure to maintain and, upon request, provide access to documentation relating to written orders or requests for payment for DME, certifications for home health services or referrals for other items or services written or ordered by such physician or supplier. Such revocation may be for no longer than one year per act.

This is scary. I hope that HHS/OIG does not take the position that an HME supplier’s number can be revoked if it does not have physicians’ progress notes in its files.

Question: For the past several years, we have had to comply with a “face-to-face” rule in the power mobility arena. Has this rule been expanded?
Answer: Yes. Sec. 6407 states that a face-to-face encounter with a patient is required before a physician may certify eligibility for home health services or DME under Medicare. As a condition of Medicare payment for DME, the physician must document that a physician, physician assistant, nurse practitioner or clinical nurse specialist has had a face-to-face encounter with the patient during the six months prior to the written order for the DME.

HHS may determine another reasonable time frame and may impose the requirement to other Medicare-covered items and services. There will be similar face-to-face requirements prior to physician certification for home health services.

Question: I have heard that the health reform legislation “speeds up” competitive bidding. Please tell me this is not true.
Answer: I wish I could tell you that, but I cannot. Under Sec. 6410, the competitive bidding program will be expanded in round two from 79 of the largest metropolitan statistical areas to 100 of the largest MSAs (i.e., Round 2 will consist of the nine MSAs from the Round 1 rebid plus 91 additional MSAs). HHS will be required either to competitively bid areas or use competitive bid prices by 2016.

Question: … and RACs are not going away, are they?
Answer: No. States must establish contracts with one or more RACs for the purpose of identifying underpayments and overpayments and recouping overpayments under the state Medicaid plan or any waiver of the state plan. The RAC program will be expanded to Medicare Parts C and D no later than Dec. 31, 2010.

Question: I understand that the health reform act hits manufacturers in the pocketbook. Correct?
Answer: Yes. Sec. 9009 imposed an annual fee on medical device manufacturers and importers. (Note: this provision was replaced with an excise tax under the Health Care and Education Reconciliation Act of 2010.)

Question: OK. So what is the Health Care and Education Reconciliation Act of 2010 (“Reconciliation Act”)?
Answer: The Reconciliation Act was signed into law on March 30, 2010. It amends the PPACA. The following is a summary of provisions that are relevant to HME suppliers:

Sec. 1302. Repeal of Prepayment Review Limits. Previously, a Medicare Administrative Contractor could conduct a prepayment review only under certain circumstances. Those limits have been removed.

Sec. 1304. 90-Day Enhanced Oversight for Initial DME Claims. After Jan. 1, 2011, if HHS determines that there is a significant risk of fraudulent activity among HME suppliers, then HHS will withhold Medicare payment of any claims submitted by a supplier that is initially enrolling in Medicare. HHS will withhold such payment during the 90-day period beginning on the date of the first submission of a claim for DME by the “new” supplier. In other words, the new supplier is placed on 90-day “probation.”

Sec. 1405. Excise Tax on Medical Device Manufacturers. This section replaced the annual fee on device manufacturers under the PPACA with an excise tax. A tax of 2.3 percent of the sales price will be imposed on the sale of any taxable medical device by the manufacturer, producer or importer. The tax will apply to sales after Dec. 31, 2012. Any device defined by the Federal Food, Drug and Cosmetic Act that is intended for humans is subject to the tax, except the following items: eyeglasses, contact lenses, hearing aids and any other medical device determined by HHS to be of a type that is purchased by the general public at retail for individual use.

Jeffrey S. Baird, Esq., is chairman of the Health Care Group at Brown & Fortunato, P.C., a law firm based in Amarillo, Texas. He represents pharmacies, infusion companies, home medical equipment companies and other health care providers throughout the United States. Baird is Board Certified in Health Law by the Texas Board of Legal Specialization. He can be reached at 806/345-6320 or jbaird@bf-law.com.


From HomeCareMag.com: News You Can Use
Having trouble keeping up? To catch up on the latest headlines, visit www.HomeCareMag.com or click below:

2009 HME Deal Total Up, but Market Challenges Discourage Buyers

New Take on Familiar Gear

Mobility Matters Documents Wheelchair Denial


To revisit this news anytime during the week, check our Web site at www.HomeCareMag.com. We welcome your comments. Drop a line to HomeCare Editor-in-Chief Gail Walker at gwalker@homecaremag.com.


ADVERTISEMENT

Visit this week's sponsor at http://UltraFill.Respironics.com


HomeCare provides its subscribers with timely legislative, regulatory and business news; in-depth analyses of various market segments; features on emerging issues and trends; practical how-to advice on business operations; best-practices profiles; and a constant stream of new product information. Subscribe to HomeCare magazine.


About this Newsletter

You are subscribed to this newsletter as #email#

To unsubscribe from this newsletter go to: Unsubscribe

To subscribe to this newsletter, go to: Subscribe

To visit HomeCare's Web site click here

For information on advertising in this newsletter, please contact Kent Peterson, National Sales Manager/Western Region Sales at kpeterson@homecaremag.com, or John McNamara, Regional Sales Manager/Eastern Region Sales at jmcnamara@homecaremag.com.

 

To get this newsletter in a different format (Text or HTML), or to change your e-mail address, please visit your profile page to change your delivery preferences.

For questions concerning delivery of this newsletter, please contact our Customer Service Department at:
Customer Service Department
HomeCare Magazine
A Penton Media publication
US Toll Free: 866-505-7173
International: 847-763-9504
Email:homecaremag@pbinews.com

Penton Media | 249 W. 17th Street | New York, NY 10011

Copyright 2010, Penton Media. All rights reserved. This article is protected by United States copyright and other intellectual property laws and may not be reproduced, rewritten, distributed, re-disseminated, transmitted, displayed, published or broadcast, directly or indirectly, in any medium without the prior written permission of Penton Media.